Literature DB >> 22710483

Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging.

Evrim B Turkbey1, Neville Gai, João A C Lima, Rob J van der Geest, Kathryn R Wagner, Gordon F Tomaselli, David A Bluemke, Saman Nazarian.   

Abstract

BACKGROUND: Patients with myotonic muscular dystrophy (DM) are at risk for atrioventricular block and left ventricular (LV) dysfunction. Noninvasive detection of diffuse myocardial fibrosis may improve disease management in this population.
OBJECTIVE: To define functional and postcontrast myocardial T1 time cardiac magnetic resonance characteristics in patients with DM.
METHODS: Thirty-three patients with DM (24 with type 1 and 9 with type 2) and 13 healthy volunteers underwent cardiac magnetic resonance for the assessment of LV indices and the evaluation of diffuse myocardial fibrosis by T1 mapping. The association of myocardial T1 time with electrocardiogram abnormalities and LV indices was examined among patients with DM.
RESULTS: Patients with DM had lower end-diastolic volume index (68.9 mL/m(2) vs 60.3 mL/m(2); P = .045) and cardiac index (2.7 L/min/m(2) vs 2.33 L/min/m(2); P = .005) and shorter myocardial T1 time (394.5 ms vs 441.4 ms; P < .0001) than did control subjects. Among patients with DM, there was a positive association between higher T1 time and LV mass index (2.2 ms longer per g/m(2); P = .006), LV end-diastolic volume index (1.3 ms longer per mL/m(2); P = .026), filtered QRS duration (1.2 ms longer per unit; P = .005), and low-amplitude (<40 mcV) late-potential duration (0.9 ms longer per unit; P = .01). Using multivariate random effects regression, each 10-ms increase in myocardial T1 time of patients with type 1 DM was independently associated with 1.3-ms increase in longitudinal PR and QRS intervals during follow-up.
CONCLUSIONS: DM is associated with structural alterations on cardiac magnetic resonance. Postcontrast myocardial T1 time was shorter in patients with DM than in controls, likely reflecting the presence of diffuse myocardial fibrosis.
Copyright © 2012 Heart Rhythm Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22710483      PMCID: PMC3459147          DOI: 10.1016/j.hrthm.2012.06.032

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  21 in total

1.  Relation of cardiac abnormalities and CTG-repeat size in myotonic dystrophy.

Authors:  J Finsterer; E Gharehbaghi-Schnell; C Stöllberger; K Fheodoroff; A Seiser
Journal:  Clin Genet       Date:  2001-05       Impact factor: 4.438

2.  An improved MR imaging technique for the visualization of myocardial infarction.

Authors:  O P Simonetti; R J Kim; D S Fieno; H B Hillenbrand; E Wu; J M Bundy; J P Finn; R M Judd
Journal:  Radiology       Date:  2001-01       Impact factor: 11.105

3.  Cardiac involvement in patients with myotonic dystrophy: characteristic features of magnetic resonance imaging.

Authors:  L De Ambroggi; A Raisaro; V Marchianó; S Radice; G Meola
Journal:  Eur Heart J       Date:  1995-07       Impact factor: 29.983

4.  Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease.

Authors:  Craig S Broberg; Sumeet S Chugh; Catherine Conklin; David J Sahn; Michael Jerosch-Herold
Journal:  Circ Cardiovasc Imaging       Date:  2010-09-20       Impact factor: 7.792

5.  Results of endomyocardial biopsy in patients with spontaneous ventricular tachycardia but without apparent structural heart disease.

Authors:  J E Strain; R M Grose; S M Factor; J D Fisher
Journal:  Circulation       Date:  1983-12       Impact factor: 29.690

Review 6.  Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases.

Authors:  H H Nguyen; J T Wolfe; D R Holmes; W D Edwards
Journal:  J Am Coll Cardiol       Date:  1988-03       Impact factor: 24.094

7.  Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I.

Authors:  Deepak Bhakta; Miriam R Lowe; William J Groh
Journal:  Am Heart J       Date:  2004-02       Impact factor: 4.749

8.  Comparison of left and right atrial volume by echocardiography versus cardiac magnetic resonance imaging using the area-length method.

Authors:  Matthew Whitlock; Anuj Garg; Jill Gelow; Timothy Jacobson; Craig Broberg
Journal:  Am J Cardiol       Date:  2010-11-01       Impact factor: 2.778

9.  Cardiac involvement in a large kindred with myotonic dystrophy. Quantitative assessment and relation to size of CTG repeat expansion.

Authors:  L S Tokgozoglu; T Ashizawa; A Pacifico; R M Armstrong; H F Epstein; W A Zoghbi
Journal:  JAMA       Date:  1995-09-13       Impact factor: 56.272

10.  Widespread electroanatomic alterations of right cardiac chambers in patients with myotonic dystrophy type 1.

Authors:  Antonio Dello Russo; Gemma Pelargonio; Quintino Parisi; Matteo Santamaria; Loredana Messano; Tommaso Sanna; Michela Casella; Giuseppe De Martino; Roberto De Ponti; Manuela Pace; Vincenzo Giglio; Carolina Ierardi; Paolo Zecchi; Filippo Crea; Fulvio Bellocci
Journal:  J Cardiovasc Electrophysiol       Date:  2006-01
View more
  15 in total

Review 1.  Tissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imaging.

Authors:  Puskar Pattanayak; David A Bleumke
Journal:  Radiol Clin North Am       Date:  2014-12-18       Impact factor: 2.303

2.  Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1.

Authors:  Lukas Chmielewski; Michael Bietenbeck; Alexandru Patrascu; Sabine Rösch; Udo Sechtem; Ali Yilmaz; Anca-Rezeda Florian
Journal:  Clin Res Cardiol       Date:  2019-02-14       Impact factor: 5.460

3.  Electrocardiographic Impact of Myocardial Diffuse Fibrosis and Scar: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Yuko Y Inoue; Bharath Ambale-Venkatesh; Nathan Mewton; Gustavo J Volpe; Yoshiaki Ohyama; Ravi K Sharma; Colin O Wu; Chia-Ying Liu; David A Bluemke; Elsayed Z Soliman; João A C Lima; Hiroshi Ashikaga
Journal:  Radiology       Date:  2016-10-13       Impact factor: 11.105

4.  Myocardial T1 mapping: techniques and potential applications.

Authors:  Jeremy R Burt; Stefan L Zimmerman; Ihab R Kamel; Marc Halushka; David A Bluemke
Journal:  Radiographics       Date:  2014 Mar-Apr       Impact factor: 5.333

5.  Cardiac autonomic function in type 1 and type 2 myotonic dystrophy.

Authors:  Piotr Bienias; Anna Łusakowska; Michał Ciurzyński; Zuzanna Rymarczyk; Katarzyna Irzyk; Michał Konwerski; Kamil Ciąpała; Paweł Kowalski; Anna Kamińska; Piotr Pruszczyk
Journal:  Clin Auton Res       Date:  2017-03-20       Impact factor: 4.435

Review 6.  Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging.

Authors:  Georgios M Alexandridis; Efstathios D Pagourelias; Nikolaos Fragakis; Maria Kyriazi; Efthymia Vargiami; Dimitrios Zafeiriou; Vassilios P Vassilikos
Journal:  Heart Fail Rev       Date:  2022-07-20       Impact factor: 4.654

Review 7.  Recent advances in myotonic dystrophy type 2.

Authors:  Christina M Ulane; Sarah Teed; Jacinda Sampson
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

Review 8.  Cardiac involvement in Duchenne and Becker muscular dystrophy.

Authors:  Sophie Mavrogeni; George Markousis-Mavrogenis; Antigoni Papavasiliou; Genovefa Kolovou
Journal:  World J Cardiol       Date:  2015-07-26

Review 9.  Myocardial T1 mapping: modalities and clinical applications.

Authors:  Christine L Jellis; Deborah H Kwon
Journal:  Cardiovasc Diagn Ther       Date:  2014-04

10.  Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study.

Authors:  Helle Petri; Kiril Aleksov Ahtarovski; Niels Vejlstrup; John Vissing; Nanna Witting; Lars Køber; Henning Bundgaard
Journal:  J Cardiovasc Magn Reson       Date:  2014-08-01       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.